WINNIPEG, MANITOBA -- (Marketwire) -- 12/01/11 -- DiaMedica Inc. (TSX VENTURE:DMA) is pleased to announce the presentation of new compelling Type...
WINNIPEG, MANITOBA--(Marketwire - Dec. 1, 2011) - DiaMedica Inc. (TSX VENTURE:DMA) is pleased to announce the presentation of new compelling Type...
WINNIPEG, MANITOBA -- (Marketwire) -- 11/29/11 -- DiaMedica Inc. (TSX VENTURE:DMA) a biopharmaceutical company focused on the development of...
WINNIPEG, MANITOBA--(Marketwire - Nov. 29, 2011) - DiaMedica Inc. (TSX VENTURE:DMA) a biopharmaceutical company focused on the development of...
WINNIPEG, MANITOBA -- (Marketwire) -- 10/27/11 -- DiaMedica Inc. (TSX VENTURE:DMA) a biopharmaceutical company focused on the development of...
WINNIPEG, MANITOBA -- (Marketwire) -- 10/12/11 -- DiaMedica Inc. (TSX VENTURE:DMA) a biopharmaceutical company focused on the development of...
WINNIPEG, MANITOBA--(Marketwire - Oct. 6, 2011) - DiaMedica Inc. (TSX VENTURE:DMA) a biopharmaceutical company focused on the development of novel...
WINNIPEG, MANITOBA--(Marketwire - Sept. 27, 2011) - DiaMedica (TSX VENTURE:DMA) today announces that Dr. Alexi Savinov of The Sanford Project has...
WINNIPEG, MANITOBA -- (Marketwire) -- 09/27/11 -- DiaMedica (TSX VENTURE: DMA) today announces that Dr. Alexi Savinov of The Sanford Project has...
WINNIPEG, MANITOBA--(Marketwire - Sept. 23, 2011) - DiaMedica Inc. ("DiaMedica") (TSX VENTURE:DMA), a biotechnology company focused on diabetes...
WINNIPEG, MANITOBA -- (Marketwire) -- 09/23/11 -- DiaMedica Inc. ("DiaMedica") (TSX VENTURE: DMA), a biotechnology company focused on diabetes, is...
WINNIPEG, MANITOBA--(Marketwire - Sept. 19, 2011) - DiaMedica (TSX VENTURE:DMA) today announces that it has been invited to present its...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.